Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults
Public ClinicalTrials.gov record NCT02610868. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Long-Term, Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects
Study identification
- NCT ID
- NCT02610868
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
- Industry
- Enrollment
- 187 participants
Conditions and interventions
Conditions
Interventions
- MYOBLOC Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2015
- Primary completion
- May 31, 2017
- Completion
- May 31, 2017
- Last update posted
- Apr 20, 2026
2015 – 2017
United States locations
- U.S. sites
- 26
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85013 | — |
| Not listed | Scottsdale | Arizona | 85258 | — |
| Not listed | Scottsdale | Arizona | 85259 | — |
| Not listed | Loma Linda | California | 92354 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | Atlantis | Florida | 33462 | — |
| Not listed | Boca Raton | Florida | 33486 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Port Charlotte | Florida | 33980 | — |
| Not listed | Atlanta | Georgia | 30329 | — |
| Not listed | Kansas City | Kansas | 66160 | — |
| Not listed | Overland Park | Kansas | 66211 | — |
| Not listed | Elkridge | Maryland | 21075 | — |
| Not listed | Farmington Hills | Michigan | 48334 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Las Vegas | Nevada | 89145 | — |
| Not listed | Edison | New Jersey | 08818 | — |
| Not listed | Centerville | Ohio | 45459 | — |
| Not listed | Tulsa | Oklahoma | 74136 | — |
| Not listed | Greenville | South Carolina | 29615 | — |
| Not listed | Cordova | Tennessee | 38018 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Kirkland | Washington | 98034 | — |
| Not listed | Spokane | Washington | 99202 | — |
| Not listed | Tacoma | Washington | 98409 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02610868, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02610868 live on ClinicalTrials.gov.